Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Novo-Nordisk

This page shows the latest Novo-Nordisk news and features for those working in and with pharma, biotech and healthcare.

Gilead and Novo Nordisk boost NASH partnership with new mid-stage study

Gilead and Novo Nordisk boost NASH partnership with new mid-stage study

The two companies first announced their NASH collaboration in 2019. Gilead and Novo Nordisk have planned a new phase 2b trial in a bid to expand their clinical collaboration in ... Gilead is pleased to expand our collaboration with Novo Nordisk and

Latest news

More from news
Approximately 149 fully matching, plus 288 partially matching documents found.

Latest Intelligence

  • Reaching patients and HCPs during the pandemic Reaching patients and HCPs during the pandemic

    Self-administered injectables, such as Novo Nordisk’s recently approved therapy for adult growth hormone deficiency (GHD), Sogroya (somapacitan), and Novartis’ much-hyped MS treatment, Kesimpta (ofatumumab), will be tested in

  • NICE – but not enough NICE – but not enough

    Around the same time (late 2018), Novo Nordisk launched Ozempic, also for type 2 diabetes, though a different class (GLP1).

  • On our best behaviour On our best behaviour

    Meanwhile, Novo Nordisk has launched Rybelsus (semaglutide) oral tablets to improve control of blood sugar – but specifically alongside diet and exercise.

  • Mapping the patient journey and minding the gap Mapping the patient journey and minding the gap

    UCB has reconfigured its teams around Patient Value Units. Novo Nordisk has established Disease Experience Expert Panels (DEEP), an approach based on ‘an evolving world view where people with serious chronic

  • Novo Nordisk awakens its ‘Sleeping Beauty’ Novo Nordisk awakens its ‘Sleeping Beauty’

    Novo Nordisk’s Biopharm is showing solid growth after a stuttering start, and its new leader believes a ‘sleeping beauty’ has been awoken. ... The small revolution we are also running in Novo Nordisk is to realise that we have many platforms at our

More from intelligence
Approximately 6 fully matching, plus 41 partially matching documents found.

Latest appointments

  • New hires at Nanoform, Leo Pharma and Calliditas New hires at Nanoform, Leo Pharma and Calliditas

    He has previously worked in various positions at Novo Nordisk, most recently as its Senior Global Regulatory Lead. ... During his time at Novo Nordisk, he led the strategic regulatory input for the orphan drug NovoEight from phase 1 through phase 3.

  • Ashfield, Health Unlimited and Ashley Communications add to their teams Ashfield, Health Unlimited and Ashley Communications add to their teams

    The latest med comms movers. Ashfield appoints Novo’s sales and marketing director. ... Van Weperen was most recently at diabetes giant Novo Nordisk, where he worked on delivering insulin and GLP1 biosimilar defence strategies, leading Novo’s UK

  • Healthcare Comms appointments Healthcare Comms appointments

    Thomas has previously held senior positions at Novo Nordisk including head of sales North, UK.

  • Lars Rebien Sørensen becomes chairman of Novo Holdings Lars Rebien Sørensen becomes chairman of Novo Holdings

    He will take up the new role 1 July. Former Novo Nordisk CEO Lars Rebien Sørensen has been appointed as Novo Holdings’ new chairman. ... years. Sørensen will succeed Sten Scheibye - who retires effective 1 July - and he will also become chairman of

  • Novo Nordisk appoints new general manager Novo Nordisk appoints new general manager

    He said: “I am delighted to join Novo Nordisk in the role of general manager in the UK. ... The vision, values and passion that is immediately evident within the company makes Novo Nordisk and exciting organisation to be a part of.

More from appointments
Approximately 10 fully matching, plus 36 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 48 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...
Oh no… not more training
Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...

Quick links

Infographics

Multimedia